Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elective Hip Replacement”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07347821
What this trial is testing

Molecular Mechanisms Underlying Hip and Knee Osteoarthritis in Patients Undergoing Primary Elective Arthroplasty

Who this might be right for
Total Hip Arthroplasty (THA)Total Knee Arthroplasty (TKA)Hip Osteoarthritis+1 more
Medical University of Warsaw 1,000
Not applicableUnknownNCT06178185
What this trial is testing

A Novel Study Evaluating Patients Awaiting Total Hip Arthroplasty (PRIORITEES)

Who this might be right for
Hip Replacement
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust 240
Not applicableWithdrawnNCT02425917
What this trial is testing

IPC-CALF Versus GEKO in Post-op Total Hip Patients

Who this might be right for
Total Hip Replacement
Firstkind Ltd
Not applicableStudy completedNCT03317145
What this trial is testing

Lower Limb Blood Flow Geko vs Foot Pump

Who this might be right for
Venous ThrombosisArthroplasty, Replacement, Hip
Hampshire Hospitals NHS Foundation Trust 10
Large-scale testing (Phase 3)Study completedNCT00329628
What this trial is testing

Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin

Who this might be right for
Venous Thromboembolism
Bayer 4,541
Large-scale testing (Phase 3)Study completedNCT00902928
What this trial is testing

A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery

Who this might be right for
Venous ThromboembolismArthroplasty, Replacement, Hip
Astellas Pharma Europe B.V. 1,992
Post-approval studies (Phase 4)Study completedNCT00145730
What this trial is testing

Prevention of Ectopic Bone Related Pain and Disability After Hip Replacement Surgery With Peri-Operative Ibuprofen

Who this might be right for
Osteoarthritis, HipArthroplasty, Replacement, HipArthritis, Rheumatoid
The George Institute 1,000
Not applicableStudy completedNCT02108847
What this trial is testing

Ultrasound Guided Fascia Iliaca Block for Pain Control After Elective Hip Replacement Surgery

Who this might be right for
Arthroplasty, Replacement, HipFascia Iliaca Block
University of Saskatchewan 42
Large-scale testing (Phase 3)Ended earlyNCT00206089
What this trial is testing

Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events

Who this might be right for
Thromboembolism
AstraZeneca 3,300
Not applicableUnknownNCT02385409
What this trial is testing

Incidence and Reasons for Preoperative Anemia in Elective Lower Joint Arthroplasty

Who this might be right for
AnemiaArthroplasty, Replacement, HipArthroplasty, Replacement, Knee
Oeivind Jans 900
Not applicableStudy completedNCT00847301
What this trial is testing

Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery

Who this might be right for
Arthroplasty, ReplacementThromboembolism
Boehringer Ingelheim 472
Large-scale testing (Phase 3)Study completedNCT00338897
What this trial is testing

Dose Ranging Study in Elective Total Hip Replacement Surgery

Who this might be right for
Venous Thromboembolism
Sanofi 1,090
Large-scale testing (Phase 3)Study completedNCT00168818
What this trial is testing

Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery

Who this might be right for
ThromboembolismArthroplasty, Replacement, Hip
Boehringer Ingelheim 3,494
Large-scale testing (Phase 3)Study completedNCT00332020
What this trial is testing

Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Who this might be right for
PreventionVenous Thromboembolism
Bayer 2,457
Large-scale testing (Phase 3)Study completedNCT00328939
What this trial is testing

ARIXTRA Local Study For Registration In China.

Who this might be right for
ThromboembolismKnee ReplacementHip Replacement
GlaxoSmithKline 240
Large-scale testing (Phase 3)Study completedNCT00345969
What this trial is testing

Exercise and Testosterone Therapy in Elderly Men With Physical Frailty

Who this might be right for
Physical FrailtyHip FractureElective Hip Replacement+1 more
Washington University School of Medicine 25
Testing effectiveness (Phase 2)Study completedNCT01225822
What this trial is testing

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 1,973
Testing effectiveness (Phase 2)Study completedNCT02170701
What this trial is testing

BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 289
Not applicableEnded earlyNCT04996420
What this trial is testing

Goal Directed Fluid Therapy Versus Liberal Fluid Regimen in Primary Elective Hip Artrhoplasty

Who this might be right for
Arthroplasty, Replacement, HipAnesthesia, SpinalHemodynamic Monitoring+1 more
Istituto Ortopedico Rizzoli 15
Testing effectiveness (Phase 2)Study completedNCT00353678
What this trial is testing

Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)

Who this might be right for
Thromboembolism
Astellas Pharma Inc 1,141
Next Page